Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous T-Cell Lymphoma (CTCL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00030589
What this trial is testing

Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma

Who this might be right for
Lymphoma
Millennix
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00101205
What this trial is testing

Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+24 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00416351
What this trial is testing

Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaSmall Intestine Cancer
Memorial Sloan Kettering Cancer Center 29
Not applicableStudy completedNCT00897923
What this trial is testing

Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Mayo Clinic 17
Testing effectiveness (Phase 2)Ended earlyNCT01579318
What this trial is testing

Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma

Who this might be right for
Cutaneous T Cell Lymphomas (CTCL)Mycosis Fungoides (MF)
OncoSec Medical Incorporated 2
Not applicableStudy completedNCT05137847
What this trial is testing

Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

Who this might be right for
Lymphoma, T-cell, PeripheralLymphoma, T-cell, Cutaneous
Eisai Inc. 118
Not applicableUnknownNCT04491825
What this trial is testing

Diagnostic Classifier for Cutaneous T-cell Lymphomas

Who this might be right for
CTCL/ Mycosis Fungoides
Medical University of Vienna 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07658924
What this trial is testing

Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma

Who this might be right for
Cutaneous T-Cell LymphomaMycosis Fungoides (MF)
Peking University First Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00038025
What this trial is testing

Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

Who this might be right for
Peripheral T-cell LymphomaCutaneous T-cell LymphomaChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 60
Early research (Phase 1)Study completedNCT01804335
What this trial is testing

CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00003210
What this trial is testing

Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+14 more
National Cancer Institute (NCI) 105
Not applicableLooking for participantsNCT06860880
What this trial is testing

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Who this might be right for
Indolent LymphomasLymphomaChronic Lymphocytic Leukemia+6 more
UNC Lineberger Comprehensive Cancer Center 40
Not applicableWithdrawnNCT00499668
What this trial is testing

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+5 more
Vanderbilt-Ingram Cancer Center
Early research (Phase 1)Study completedNCT02342782
What this trial is testing

Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma

Who this might be right for
Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin LymphomaRefractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma+2 more
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT03357224
What this trial is testing

PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)

Who this might be right for
Lymphoma, T-Cell, CutaneousMycosis Fungoides/Sezary Syndrome
European Organisation for Research and Treatment of Cancer - EORTC 26
Testing effectiveness (Phase 2)Study completedNCT05380635
What this trial is testing

PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma

Who this might be right for
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Soligenix 9
Testing effectiveness (Phase 2)Study completedNCT02643303
What this trial is testing

Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Who this might be right for
Head and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more
Ludwig Institute for Cancer Research 58
Next Page